CAN, N. Ö. Et Al. 2017. Identification of a Novel Metabolite Originating from AM-630, a Potent and Selective Inverse Agonist for the Cannabinoid Receptor CB2. 9th International Congress on Psychopharmacology 5th International Symposium on Child and Adolescent Psychopharmacology .

CAN, N. Ö., ÖZKAY, Y., LEVENT, S., TURAN, N., ALYU, F., & ÖZTÜRK, Y., (2017). Identification of a Novel Metabolite Originating from AM-630, a Potent and Selective Inverse Agonist for the Cannabinoid Receptor CB2 . 9th International Congress on Psychopharmacology 5th International Symposium on Child and Adolescent Psychopharmacology

CAN, NAFİZ Et Al. "Identification of a Novel Metabolite Originating from AM-630, a Potent and Selective Inverse Agonist for the Cannabinoid Receptor CB2," 9th International Congress on Psychopharmacology 5th International Symposium on Child and Adolescent Psychopharmacology, 2017

CAN, NAFİZ Ö. Et Al. "Identification of a Novel Metabolite Originating from AM-630, a Potent and Selective Inverse Agonist for the Cannabinoid Receptor CB2." 9th International Congress on Psychopharmacology 5th International Symposium on Child and Adolescent Psychopharmacology , 2017

CAN, N. Ö. Et Al. (2017) . "Identification of a Novel Metabolite Originating from AM-630, a Potent and Selective Inverse Agonist for the Cannabinoid Receptor CB2." 9th International Congress on Psychopharmacology 5th International Symposium on Child and Adolescent Psychopharmacology .

@conferencepaper{conferencepaper, author={NAFİZ ÖNCÜ CAN Et Al. }, title={Identification of a Novel Metabolite Originating from AM-630, a Potent and Selective Inverse Agonist for the Cannabinoid Receptor CB2}, congress name={9th International Congress on Psychopharmacology 5th International Symposium on Child and Adolescent Psychopharmacology}, city={}, country={}, year={2017}}